Literature DB >> 20740343

Malignant potential of intraductal papillary mucinous neoplasms of the pancreas.

Yoshiyuki Nakajima1, Takatsugu Yamada, Masayuki Sho.   

Abstract

An intraductal papillary mucinous neoplasm (IPMN) is now a well-recognized disease entity. In general, the prognosis of IPMN is much more favorable than that of pancreatic ductal adenocarcinoma (PDAC). However, IPMN has a broad biological spectrum and it sometimes progresses, slowly showing neoplastic transformations. International consensus guidelines have been recently proposed for the management of IPMN. While they significantly contribute to appropriate management of IPMN, various issues including the natural history and malignant potential of IPMN are not fully elucidated. This review focuses on the malignant potential, including the postoperative recurrence of IPMN, coincidence of IPMN with PDAC, and extrapancreatic malignancy that may affect the long-term survival of the patients rather than IPMN itself.

Entities:  

Mesh：

Year:  2010        PMID： 20740343     DOI： 10.1007/s00595-009-4227-y

Source DB:  PubMed          Journal:  Surg Today        ISSN： 0941-1291            Impact factor:   2.549


  88 in total

Review 1.  Clinical importance of precursor lesions in the pancreas.

Authors:  Ralph H Hruban; Kyoichi Takaori; Marcia Canto; Elliot K Fishman; Kurtis Campbell; Kieran Brune; Scott E Kern; Michael Goggins
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-05-29

2.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas.

Authors:  E Cuillerier; C Cellier; L Palazzo; J Devière; P Wind; F Rickaert; P H Cugnenc; M Cremer; J P Barbier
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

4.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Authors:  Toru Furukawa; Günter Klöppel; N Volkan Adsay; Jorge Albores-Saavedra; Noriyoshi Fukushima; Akira Horii; Ralph H Hruban; Yo Kato; David S Klimstra; Daniel S Longnecker; Jutta Lüttges; G Johan A Offerhaus; Michio Shimizu; Makoto Sunamura; Arief Suriawinata; Kyoichi Takaori; Suguru Yonezawa
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

5.  Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Authors:  F Maire; P Hammel; B Terris; F Paye; J-Y Scoazec; C Cellier; M Barthet; D O'Toole; P Rufat; C Partensky; E Cuillerier; P Lévy; J Belghiti; P Ruszniewski
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

6.  Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination.

Authors:  F Paye; A Sauvanet; B Terris; P Ponsot; V Vilgrain; P Hammel; P Bernades; P Ruszniewski; J Belghiti
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

7.  Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Terumi Kamisawa; Yuyang Tu; Naoto Egawa; Hitoshi Nakajima; Kouji Tsuruta; Atsutake Okamoto
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

8.  Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.

Authors:  Koji Yoshizawa; Hideo Nagai; Shinji Sakurai; Mitsugu Hironaka; Shojiroh Morinaga; Ken Saitoh; Masashi Fukayama
Journal:  Virchows Arch       Date:  2002-10-12       Impact factor: 4.064

9.  Clinicopathologic features of re-resected cases of intraductal papillary mucinous neoplasms (IPMNs).

Authors:  Yukihiro Yokoyama; Masato Nagino; Koji Oda; Hideki Nishio; Tomoki Ebata; Tetsuya Abe; Tsuyoshi Igami; Yuji Nimura
Journal:  Surgery       Date:  2007-08       Impact factor: 3.982

10.  Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma.

Authors:  Stefan Fritz; Carlos Fernandez-del Castillo; Mari Mino-Kenudson; Stefano Crippa; Vikram Deshpande; Gregory Y Lauwers; Andrew L Warshaw; Sarah P Thayer; A John Iafrate
Journal:  Ann Surg       Date:  2009-03       Impact factor: 12.969
View more
  2 in total

1.  A one-stage operation for abdominal aortic aneurysm and intraductal papillary mucinous neoplasms of the pancreas: report of a case.

Authors:  Yoshihiko Tsuji; Ikurou Kitano; Katsuhiro Sawada
Journal:  Surg Today       Date:  2012-01-26       Impact factor: 2.549

2.  Increased prevalence of colorectal neoplasia in patients with intraductal papillary mucinous neoplasms.

Authors:  Dana Zelnik Yovel; Lior Bear; Erez Scapa; Mati Shnell; Iddo Bar Yishay; Nir Bar; Tomer ZIv Baran; Fadi Younis; Adam Phillips; Nir Lubezky; Oren Shibolet; Dana Ben-Ami Shor
Journal:  Therap Adv Gastroenterol       Date:  2022-06-16       Impact factor: 4.802
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.